SCHEMBL6826702

SCHEMBL6826702

CC(C)C(CO)NC=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10433346 1.00
SCHEMBL18823383 0.83
SCHEMBL18712322 0.83
SCHEMBL18823486 0.83
SCHEMBL6827518 0.79 ADH1B (0.39)
SCHEMBL271892 0.77
SCHEMBL24138686 0.75 ADH1B (0.43)
SCHEMBL9760970 0.75 AKR1B1 (0.36)
SCHEMBL2702509 0.74
SCHEMBL105725 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1523493-B1 NOVEL TUBULYSIN ANALOGUES DOEMLING ALEXANDER (DE) 2013-09-04 EP disclosed
US-7816377-B2 Tubulysin analogues R&D-BIOPHARMACEUTICALS GMBH (DE) 2010-10-19 US disclosed
US-7816377-B2 Tubulysin analogues R&D-BIOPHARMACEUTICALS GMBH (DE) 2010-10-19 US disclosed
US-20040067999-A1 Carbazole derivatives and their use as neuropeptide y5 receptor ligands ASTRAZENECA AB (SE) 2004-04-08 US disclosed
EP-1358157-A1 CARBAZOLE DERIVATIVES AND THEIR USE AS NEUROPEPTIDE Y5 RECEPTOR LIGANDS AstraZeneca AB (SE) 2003-11-05 EP disclosed
WO-2002051806-A1 CARBAZOLE DERIVATIVES AND THEIR USE AS NEUROPEPTIDE Y5 RECEPTOR LIGANDS ASTRAZENECA AB (SE) 2002-07-04 WO disclosed
EP-0353732-A2 Fluoro-olefins, method for their preparation and their use CIBA-GEIGY AG (CH) 1990-02-07 EP disclosed